Patient Management

2074 questions

Question 741Question →

Match each ambulatory patient profile with the most appropriate, guideline-concordant preventive care intervention or recommendation.

Click a left item, then click its matching right item

Items

52-year-old male; 2525 pack-year smoking history, quit 88 years ago; recent colonoscopy and lipid panel are normal
55-year-old male with type 2 diabetes mellitus; blood pressure 128/80 mmHg128/80 \text{ mmHg}; recent LDL-C is 90 mg/dL90 \text{ mg/dL}
28-year-old female at 2828 weeks gestation; received a Tdap booster 22 years ago for a laceration; standard prenatal screening negative
66-year-old female; total hysterectomy for benign uterine fibroids at age 5050; history of normal Pap smears prior to surgery

Matches

Show answer & explanation

Answer

The 52-year-old former heavy smoker requires annual LDCT. The 55-year-old diabetic male requires moderate-intensity statin therapy. The 28-year-old pregnant female requires a Tdap vaccine. The 66-year-old female with a prior total hysterectomy for benign fibroids requires discontinuation of cervical cancer screening.
Each match strictly follows the primary prevention pathways outlined by the USPSTF and ACIP, correctly identifying the defining clinical variable (smoking pack-years, diabetes status, gestational age, surgical history) that triggers the respective intervention.

Step-by-Step Solution

1
Evaluate the 52-year-old male's risk factors.
He meets criteria for annual low-dose computed tomography (LDCT).
He falls within the 5050-8080 age range, has a smoking history of >20>20 pack-years, and quit within the last 1515 years.
2
Evaluate the 55-year-old male with type 2 diabetes.
He meets criteria for initiating moderate-intensity statin therapy.
Any patient aged 4040 to 7575 with diabetes mellitus qualifies for statin therapy for primary prevention, even if their LDL-C is relatively controlled (e.g., 90 mg/dL90 \text{ mg/dL}).
3
Evaluate the 28-year-old pregnant female's vaccination status.
She must receive the Tdap vaccine now.
Tdap is strictly indicated in the third trimester (2727-3636 weeks) of every pregnancy to maximize passive infant immunity, superseding the usual 1010-year booster interval.
4
Evaluate the 66-year-old female's cancer screening requirements.
She qualifies for discontinuation of cervical cancer screening.
She has no cervix (post-total hysterectomy) and the surgery was for a benign indication (fibroids), removing the anatomic substrate for typical cervical cancer.

Key Concept

Application of age- and risk-specific preventive care guidelines (USPSTF and ACIP)
Question 742Question →

A 68-year-old man presents to the clinic with severe pain, swelling, and redness in his right knee that began abruptly 18 hours ago. He has a history of poorly controlled type 2 diabetes mellitus, diabetic nephropathy, and hypertension. His current medications include insulin glargine, insulin lispro, and amlodipine. Vital signs show a temperature of 37.3°C (99.1°F), blood pressure of 145/88 mmHg, and heart rate of 88/min. Physical examination reveals an erythematous, markedly swollen, and exquisitely tender right knee with severely limited range of motion.

Laboratory studies reveal:
- Serum creatinine: 2.7 mg/dL (baseline 2.5 mg/dL)
- Estimated GFR: 24 mL/min/1.73 m²
- Serum glucose: 345 mg/dL
- Hemoglobin A1c: 10.4%

Arthrocentesis of the right knee yields 4 mL of turbid yellow fluid. Synovial fluid analysis shows a leukocyte count of 22,000/mm³ with 85% neutrophils. Polarized light microscopy demonstrates numerous needle-shaped, negatively birefringent crystals. Gram stain of the fluid shows no organisms.

Which of the following is the most appropriate pharmacologic intervention for this patient's acute joint condition?

Show answer & explanation

Answer: Intra-articular triamcinolone

Answer

Intra-articular triamcinolone
Intra-articular triamcinolone is the most appropriate next step in management for this patient. The treatment of an acute gout flare typically involves NSAIDs, colchicine, or systemic corticosteroids. However, the choice of agent is heavily dictated by patient comorbidities. This patient has advanced chronic kidney disease (stage 4) and severely uncontrolled diabetes. A localized intra-articular corticosteroid injection provides excellent anti-inflammatory relief for a single affected joint without causing the systemic side effects that would compromise his renal or metabolic status.

Step-by-Step Solution

1
Diagnose the acute condition based on clinical presentation and synovial fluid analysis.
The patient has an acute gout flare, confirmed by the presence of numerous needle-shaped, negatively birefringent crystals.
Accurate diagnosis is required before selecting targeted pharmacologic therapy.
2
Evaluate the patient's baseline comorbidities and current metabolic state.
The patient has advanced chronic kidney disease (eGFR 24 mL/min/1.73 m²) and severe, poorly controlled diabetes mellitus (glucose 345 mg/dL, HbA1c 10.4%).
Comorbidities significantly restrict the available therapeutic options for acute gout.
3
Screen standard first-line gout therapies for contraindications against the identified comorbidities.
NSAIDs and colchicine are contraindicated due to advanced CKD. Systemic corticosteroids are highly unfavorable due to uncontrolled severe hyperglycemia.
Administering standard systemic agents would cause significant iatrogenic harm, such as acute renal failure or a hyperglycemic crisis.
4
Select the most appropriate alternative intervention.
Intra-articular triamcinolone is chosen as the safest and most effective targeted therapy.
A localized injection treats the monoarticular flare effectively without producing the harmful systemic effects associated with oral agents.

Key Concept

In patients with acute monoarticular gout who have multiple systemic contraindications (such as advanced CKD precluding NSAIDs/colchicine, and uncontrolled diabetes precluding systemic steroids), intra-articular corticosteroid injection is the treatment of choice.
Estimated Time:1m 15s
Question 743Question →

During a routine health maintenance visit, a 4242-year-old woman reports difficulty performing fine motor tasks at work due to a bilateral hand tremor. The tremor is most prominent during voluntary movements. She is diagnosed with essential tremor and requests medical therapy. Her medical records indicate a longstanding history of moderate persistent asthma, currently managed with a daily budesonide inhaler and an as-needed albuterol inhaler. As the physician considers initiating pharmacotherapy for her tremor, which of the following agents should be avoided?

Show answer & explanation

Answer: Propranolol

Answer

Propranolol
The correct answer is propranolol. Propranolol is a non-selective beta-adrenergic antagonist frequently used as a first-line treatment for essential tremor. However, because it antagonizes β2\beta_2 receptors in the bronchial smooth muscle, it can precipitate severe bronchospasm. Therefore, it is absolutely contraindicated in patients with reactive airway diseases such as asthma. Patients with essential tremor and concurrent asthma should instead be offered alternative first-line agents, such as primidone.

Step-by-Step Solution

1
Identify the patient's primary diagnosis and the secondary comorbidity.
The patient requires treatment for essential tremor and has a comorbid diagnosis of moderate persistent asthma.
Choosing a pharmacologic intervention requires reviewing the patient's medical history for potential contraindications.
2
Evaluate standard therapies for essential tremor against the patient's asthma.
Propranolol, a non-selective beta-blocker, is a first-line treatment for essential tremor but can trigger severe bronchospasm in asthmatic patients.
Non-selective beta-blockers antagonize β2\beta_2 receptors in the lungs, reversing or preventing the bronchodilatory effects of endogenous catecholamines and medications like albuterol.
3
Determine the contraindicated medication.
Propranolol must be avoided; the patient should be offered an alternative such as primidone.
Patient safety dictates avoiding medications that directly exacerbate underlying chronic conditions when safe alternatives exist.

Key Concept

Absolute contraindications to non-selective beta-blockers in patients with reactive airway disease.
Question 744Question →

A 59-year-old man presents to the clinic for follow-up of Crohn's disease and gout. His Crohn's disease has been well-controlled for the past three years on a stable dose of azathioprine (150 mg daily). However, he has experienced three severe gout flares over the last six months. He brings a new prescription for allopurinol 100 mg daily from his rheumatologist and asks for advice regarding the safety of combining these medications before taking his first dose. His current laboratory results, including a complete blood count and comprehensive metabolic panel, are within normal limits. Which of the following is the most appropriate next step in the management of this patient's medication regimen?

Show answer & explanation

Answer: Reduce the azathioprine dose to approximately one-quarter of its current amount

Answer

Reduce the azathioprine dose to approximately one-quarter of its current amount
Azathioprine is a prodrug that is converted into 6-mercaptopurine (6-MP). 6-MP is subsequently metabolized by three primary enzymatic pathways: xanthine oxidase (XO) to inactive thiouric acid, thiopurine methyltransferase (TPMT) to inactive methyl-mercaptopurine, and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) to active 6-thioguanine nucleotides (6-TGN). Allopurinol is an XO inhibitor. When administered concurrently with azathioprine, allopurinol blocks the inactivation of 6-MP, drastically shunting its metabolism toward the production of 6-TGN. High intracellular levels of 6-TGN can cause severe, potentially life-threatening myelosuppression. Therefore, when initiating allopurinol in a patient already taking azathioprine, the azathioprine dose must be preemptively reduced to 25% to 33% (approximately one-quarter) of its original dose, and complete blood counts should be monitored closely.

Step-by-Step Solution

1
Analyze the patient's current medication regimen and the newly prescribed drug.
The patient is taking azathioprine and is about to start allopurinol for recurrent gout.
Identifying potential drug-drug interactions is critical before initiating new therapies, especially with immunosuppressants.
2
Identify the specific pharmacokinetic interaction between the two medications.
Allopurinol is a xanthine oxidase inhibitor. Azathioprine is converted to 6-mercaptopurine, which relies on xanthine oxidase for metabolism into inactive thiouric acid.
Understanding the metabolic pathways helps predict the clinical consequence of the interaction.
3
Determine the clinical consequence of this enzymatic inhibition.
Inhibition of xanthine oxidase shunts 6-mercaptopurine metabolism toward the production of active, toxic 6-thioguanine nucleotides (6-TGN), leading to severe bone marrow suppression.
This identifies the risk of life-threatening toxicity if both drugs are taken at standard doses.
4
Select the appropriate evidence-based management strategy.
The dose of azathioprine must be preemptively reduced to 25% to 33% of its original dose to prevent toxicity while maintaining efficacy.
This allows the patient to safely benefit from both therapies without risking severe myelosuppression.

Key Concept

Pharmacokinetic interaction between azathioprine/6-mercaptopurine and xanthine oxidase inhibitors
Question 745Question →

A 28-year-old man is brought to the emergency department 30 minutes after falling approximately 25 feet from a scaffold. He complains of excruciating pelvic and lower back pain. He has no significant past medical history. His temperature is 36.8°C (98.2°F), blood pressure is 80/40 mmHg, heart rate is 134/min, and respiratory rate is 24/min. Physical examination reveals blood at the urethral meatus. There is marked instability of the pelvic ring in response to gentle manual compression. A cervical spine collar is in place. Intravenous access is established with two large-bore peripheral lines, and a massive transfusion protocol is initiated. A bedside Focused Assessment with Sonography for Trauma (FAST) examination shows no intraperitoneal free fluid. A portable chest radiograph is unremarkable. An anteroposterior pelvic radiograph demonstrates widening of the pubic symphysis to 4.5 cm and disruption of the right sacroiliac joint. Despite receiving 2 liters of warmed crystalloid and 2 units of uncrossmatched packed red blood cells, his blood pressure remains 82/45 mmHg and heart rate is 130/min.

Which of the following are appropriate next steps in the procedural management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Application of a pelvic circumferential compression device at the level of the greater trochanters; Pelvic angiography with transcatheter arterial embolization

Answer

The appropriate procedural interventions for this patient are the application of a pelvic circumferential compression device (pelvic binder) and pelvic angiography with transcatheter arterial embolization.
This patient presents with hemorrhagic shock secondary to a severe 'open-book' pelvic fracture, evidenced by the widened pubic symphysis and sacroiliac joint disruption. The FAST exam is negative, indicating that the life-threatening bleeding is confined to the retroperitoneal space rather than the peritoneal cavity. The immediate priority in procedural management is to stabilize the pelvic ring to decrease pelvic volume, which promotes tamponade of the actively bleeding presacral venous plexus. This is most rapidly achieved by applying a pelvic circumferential compression device (pelvic binder) centered over the greater trochanters. Because the patient remains hemodynamically unstable despite aggressive volume resuscitation and mechanical stabilization, definitive control of arterial hemorrhage is additionally required. The standard of care for identifying and halting ongoing arterial bleeding (typically from branches of the internal iliac artery) in this setting is pelvic angiography with transcatheter arterial embolization.

Step-by-Step Solution

1
Evaluate the patient's hemodynamic status and trauma primary survey findings.
The patient is in persistent hemorrhagic shock (BP 82/45 mmHg) with an unstable 'open-book' pelvic fracture and a negative FAST exam.
Identifying the severity of shock and accurately localizing the bleeding source is essential to direct life-saving therapeutic interventions.
2
Determine the most likely source of the life-threatening hemorrhage.
The combination of a massive pelvic ring disruption and a negative FAST localizes the primary bleeding to the retroperitoneal space.
Pelvic fractures cause massive retroperitoneal bleeding originating from the presacral venous plexus and internal iliac arterial branches, without necessarily causing intraperitoneal bleeding.
3
Select the procedures that provide immediate mechanical stabilization and definitive vascular control.
Application of a pelvic binder and subsequent pelvic angiography with embolization (or preperitoneal packing) are indicated.
The binder immediately reduces pelvic volume to promote venous tamponade, while angiography provides definitive control of arterial hemorrhage.

Key Concept

Hemodynamically unstable patients with severe pelvic ring disruptions and no evidence of intraperitoneal hemorrhage on FAST require immediate application of a pelvic binder for mechanical tamponade, followed by pelvic angiography with embolization (or preperitoneal packing) to control retroperitoneal bleeding.
Question 746Question →

A 29-year-old pregnant woman, gravida 2, para 1, is evaluated in the outpatient clinic for a routine prenatal visit at 28 weeks gestation. She has no chronic medical conditions and takes only a daily prenatal vitamin. She has never smoked cigarettes, consumed alcohol, or used illicit drugs. Her last cervical cancer screening was at age 27 and was normal. During her previous pregnancy three years ago, she received all standard prenatal care and immunizations. Today, her blood pressure is 112/70 mm Hg and her heart rate is 78/min. Fetal heart tones are normal. Which of the following is the most appropriate immunization to administer to this patient at this visit?

Show answer & explanation

Answer: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine

Answer

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine
The correct action is to administer the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. The Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists (ACOG) strongly recommend administering the Tdap vaccine during every pregnancy, optimally between 27 and 36 weeks of gestation. This timing maximizes the maternal antibody response and subsequent transplacental transfer of IgG antibodies, which provides critical passive immunity against pertussis to the newborn during the first few months of life before the infant can receive their own primary series. This requirement applies regardless of whether the patient received Tdap during a previous pregnancy or how recently a prior dose was given.

Step-by-Step Solution

1
Identify the patient's current physiological state.
The patient is at 28 weeks gestation in an otherwise uncomplicated pregnancy.
Pregnancy alters standard vaccination protocols, providing specific indications and absolute contraindications.
2
Determine the indication for Tdap vaccination.
The Tdap vaccine is specifically recommended between 27 and 36 weeks of gestation for every pregnancy.
Maternal immunization during this window maximizes the transfer of protective pertussis antibodies to the fetus, protecting the neonate during the most vulnerable early months of life.
3
Evaluate the safety of the other listed vaccines.
MMR, Varicella, and live attenuated influenza vaccines are live-virus vaccines.
Live-virus vaccines are strictly contraindicated during pregnancy due to the theoretical risk of transmitting the vaccine virus to the fetus.

Key Concept

The Tdap vaccine is recommended during every pregnancy, ideally between 27 and 36 weeks of gestation, regardless of the patient's prior vaccination history. Live-virus vaccines are strictly contraindicated during pregnancy.
Question 747Question →

A 64-year-old man is hospitalized for an acute deep vein thrombosis of the right lower extremity. He is promptly started on a continuous unfractionated heparin infusion. On admission (hospital day 1), his platelet count is 240,000/mm³. On hospital day 5, routine morning laboratory studies reveal a platelet count of 90,000/mm³. The patient remains hemodynamically stable, reports no new symptoms, and physical examination reveals no petechiae, ecchymoses, or signs of active bleeding. His right leg swelling has improved. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue the unfractionated heparin and initiate an argatroban infusion

Answer

Discontinue the unfractionated heparin and initiate an argatroban infusion
The correct answer correctly identifies that a >50% drop in platelet count occurring 5 to 10 days after the initiation of unfractionated heparin is highly suspicious for Heparin-Induced Thrombocytopenia (HIT). The most critical initial step in managing suspected HIT is the immediate discontinuation of all heparin products. Furthermore, because HIT is a highly prothrombotic state, patients require immediate anticoagulation with a non-heparin agent, such as a direct thrombin inhibitor (argatroban or bivalirudin) or fondaparinux, to prevent life-threatening thrombotic complications.

Step-by-Step Solution

1
Evaluate the change in platelet count relative to the timeline of heparin administration.
The platelet count dropped from 240,000 to 90,000 (a >50% decrease) occurring on hospital day 5.
This specific timing and magnitude of platelet drop is the classic hallmark of Type II Heparin-Induced Thrombocytopenia (HIT).
2
Determine the necessary treatment modification based on the suspected diagnosis of HIT.
All heparin products must be stopped, and a non-heparin anticoagulant must be started.
HIT is a highly prothrombotic state caused by antibodies to the heparin-PF4 complex. A direct thrombin inhibitor like argatroban is required to prevent catastrophic thrombosis while the platelet count recovers.

Key Concept

Monitoring for and managing Heparin-Induced Thrombocytopenia (HIT)
Question 748Question →

A 59-year-old man is evaluated on hospital day 28 for disposition planning. He was initially admitted for severe acute necrotizing pancreatitis complicated by infected pseudocysts, requiring multiple exploratory laparotomies. He is currently hemodynamically stable and was successfully weaned from mechanical ventilation five days ago. He now breathes room air via a tracheostomy collar. Enteral feeding is provided via a percutaneous endoscopic gastrostomy tube. He is receiving intravenous meropenem for a multidrug-resistant abdominal fluid collection, with three weeks of therapy remaining. A large, complex midline abdominal wound is being managed with negative pressure wound therapy. The patient is alert and cooperative. He exhibits profound generalized weakness and becomes exhausted after 20 minutes of physical therapy. Daily laboratory results have been stable for the past week, and his clinical condition only requires weekly physician assessments. Which of the following is the most appropriate next step in the care transition for this patient?

Show answer & explanation

Answer: Transfer to a subacute skilled nursing center

Answer

Transfer to a subacute skilled nursing center
The correct disposition for this patient is a subacute skilled nursing center. This patient presents with multiple highly complex care needs, including tracheostomy management, enteral feeding via a PEG tube, prolonged intravenous antibiotics, and complex wound care with a negative pressure device. These interventions require reliable, daily, around-the-clock skilled nursing care. However, the patient is medically stable, has been successfully weaned from mechanical ventilation, and does not require daily acute physician intervention. Because he lacks the need for hospital-level acute care, a long-term acute care facility is unnecessary and represents over-utilization of resources. Furthermore, his profound deconditioning prevents him from participating in the 3 hours of daily therapy required for admission to an acute rehabilitation unit. A subacute skilled nursing facility is the ideal setting; it provides the intensive daily nursing care he needs while offering a more gradual, slower-paced physical therapy program appropriate for his current stamina.

Step-by-Step Solution

1
Evaluate the patient's medical stability and need for physician oversight.
The patient is hemodynamically stable, weaned from the ventilator, and only requires weekly physician assessments.
This rules out the need for a long-term acute care facility, which is reserved for medically unstable patients needing daily acute physician intervention.
2
Assess the complexity of the patient's nursing care requirements.
The patient requires tracheostomy care, PEG tube feeding, long-term intravenous antibiotics, and complex negative pressure wound therapy.
These highly complex interventions demand 24-hour skilled nursing care, ruling out discharge to home or a custodial care facility.
3
Determine the patient's functional capacity and tolerance for rehabilitation.
The patient becomes exhausted after 20 minutes of physical therapy.
This prevents admission to an acute rehabilitation unit, which mandates that patients actively participate in at least 3 hours of intensive therapy per day.
4
Match the patient's clinical profile to the appropriate post-acute care setting.
A subacute skilled nursing center provides the required 24-hour skilled nursing care along with a slower-paced rehabilitation program.
This setting perfectly balances his need for complex nursing interventions without the requirement for acute physician oversight or high-intensity physical therapy.

Key Concept

Appropriate patient disposition relies on matching medical stability, skilled nursing requirements, and rehabilitation tolerance to strictly defined post-acute care criteria.
Question 749Question →

A 34-year-old woman is evaluated in the outpatient clinic for a 1-year history of progressive weight gain, easy bruising, and new-onset facial hair growth. She reports increased difficulty climbing stairs due to muscle weakness. She does not take any exogenous corticosteroids, over-the-counter supplements, or herbal medications. Vital signs show a blood pressure of 158/96 mmHg and a body mass index of 34 kg/m². Physical examination reveals central obesity, facial plethora, supraclavicular fat pads, and wide violaceous striae over the lower abdomen. There is high clinical suspicion for endogenous Cushing syndrome.

Assuming the diagnostic workup ultimately confirms Cushing disease (an adrenocorticotropic hormone-secreting pituitary adenoma), arrange the following diagnostic tests in the correct sequential order from initial screening to final anatomic localization.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) 24-hour urine free cortisol or 1-mg overnight dexamethasone suppression test, 2) Plasma ACTH measurement, 3) High-dose dexamethasone suppression test, 4) MRI of the sella turcica.
The diagnostic workup of Cushing syndrome must strictly follow a biochemical-to-anatomical pipeline to prevent misdiagnosis. It begins with screening tests to confirm hypercortisolism (24-hour UFC, 1-mg DST, or late-night salivary cortisol). Once confirmed, ACTH levels are drawn to distinguish ACTH-dependent from ACTH-independent causes. If ACTH is normal or elevated, a high-dose DST or CRH stimulation test is used to localize the source to either the pituitary or an ectopic site. Only after biochemical tests indicate a pituitary source should an MRI of the sella turcica be ordered.

Step-by-Step Solution

1
Confirm endogenous hypercortisolism.
Abnormal screening test (e.g., elevated urine free cortisol).
Before attempting to identify a specific anatomical source, the presence of pathological cortisol excess must be definitively established to prevent false-positive diagnostic cascades.
2
Determine ACTH dependence.
Normal or elevated plasma ACTH level.
This step cleanly separates primary adrenal causes (ACTH-independent, where ACTH is suppressed) from pituitary or ectopic causes (ACTH-dependent).
3
Differentiate the specific source of ACTH production.
Cortisol suppression on a high-dose dexamethasone suppression test.
This distinguishes a pituitary adenoma (Cushing disease), which retains some negative feedback response, from ectopic ACTH secretion (e.g., small cell lung cancer), which typically does not respond to feedback.
4
Localize the anatomical lesion.
Identification of a pituitary microadenoma on imaging.
Imaging is strictly targeted based on biochemical confirmation. Premature imaging is dangerous due to the high prevalence of non-functioning incidentalomas in the general population.

Key Concept

Diagnostic sequencing for suspected Cushing syndrome
Question 750Question →

A 68-year-old man presents to the clinic to discuss management of newly diagnosed nonvalvular atrial fibrillation. His medical history includes hypertension, type 2 diabetes mellitus, and osteoarthritis. His current medications include lisinopril, metformin, and acetaminophen. His blood pressure is 134/82 mmHg, and his pulse is 88/min and irregularly irregular. The physician and patient agree to initiate apixaban therapy for stroke prophylaxis. Which of the following parameters must be evaluated prior to initiation and monitored periodically during this specific pharmacotherapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Complete blood count; Serum creatinine

Answer

Complete blood count and serum creatinine
The correct choices are complete blood count and serum creatinine. Prior to initiating any systemic anticoagulant therapy, obtaining a baseline complete blood count is essential to document baseline hemoglobin and platelet levels. This helps in identifying underlying abnormalities and provides a reference point for monitoring potential occult bleeding during therapy. Furthermore, apixaban is partially cleared by the kidneys. Renal function, assessed via serum creatinine to estimate creatinine clearance, must be evaluated at baseline to ensure appropriate, safe dosing and to prevent drug accumulation. Renal function and complete blood count should subsequently be monitored periodically (at least annually, or more frequently depending on the patient's baseline renal impairment and clinical status).

Step-by-Step Solution

1
Identify the chosen pharmacotherapy and its class.
Apixaban, which is a direct oral anticoagulant (DOAC) acting as a factor Xa inhibitor.
The drug class and mechanism of action dictate the specific baseline screening and ongoing monitoring requirements.
2
Determine the required baseline and ongoing laboratory testing for apixaban.
Baseline assessment of hemoglobin, platelets (via complete blood count), and renal function (via serum creatinine) is required.
Renal function must be evaluated to ensure safe dosing and prevent drug accumulation, while a complete blood count establishes a baseline to monitor for clinically significant bleeding or thrombocytopenia over time.
3
Evaluate the need for routine coagulation assays or advanced diagnostic imaging.
Neither routine coagulation assays nor head imaging are indicated in this scenario.
Unlike older anticoagulants, DOACs have highly predictable pharmacokinetics and do not require titration based on coagulation parameters. Furthermore, asymptomatic patients do not require neuroimaging prior to initiation.

Key Concept

Baseline and ongoing monitoring requirements for direct oral anticoagulants (DOACs)
Question 751Question →

An emergency medical services team brings a 64-year-old male patient to the resuscitation bay after he lost consciousness at a local fitness center. He is currently awake but complains of severe, sharp anterior chest pain that radiates to his jaw. His medical history is significant for poorly controlled hypertension.

Vital signs are temperature 37.0°C (98.6°F), blood pressure 82/45 mmHg, heart rate 118/min, and respiratory rate 24/min. Pulse oximetry shows 94% on room air.

Physical examination reveals a diaphoretic, pale man in marked distress. The jugular venous pressure is estimated at 14 cm H2O. Cardiac auscultation reveals distant heart sounds. Lungs are clear to auscultation bilaterally. Pulses are weak but symmetric in all extremities.

A bedside point-of-care ultrasound is performed immediately. The parasternal long-axis view demonstrates a large circumferential pericardial effusion with right ventricular free wall bowing inward during diastole. Additionally, an echogenic linear flap is visualized undulating within a significantly dilated aortic root.

Which of the following is the most appropriate next step in the procedural management of this patient?

Show answer & explanation

Answer: Emergency operative intervention for aortic reconstruction

Answer

Emergency operative intervention for aortic reconstruction
The patient's clinical presentation and bedside ultrasound findings confirm a Stanford Type A aortic dissection complicated by cardiac tamponade (hemopericardium). In hemodynamically unstable patients with this dual diagnosis, the definitive and only appropriate management is emergent open surgical repair (via median sternotomy). The tamponade acts as a temporary pressure seal against the ruptured aortic wall. Relieving this pressure prematurely outside the operating room is contraindicated, making immediate surgical intervention the necessary next step.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the physical examination.
The patient presents with hypotension, elevated jugular venous pressure, and distant heart sounds (Beck's triad), indicating cardiogenic or obstructive shock, specifically cardiac tamponade.
Recognizing shock physiology dictates the urgency and focuses the interpretation of diagnostic adjuncts.
2
Analyze the bedside point-of-care ultrasound findings.
The ultrasound confirms cardiac tamponade (pericardial effusion with right ventricular diastolic collapse) and identifies the underlying etiology as a Stanford Type A aortic dissection (echogenic flap in the aortic root).
Ultrasound rapidly identifies the exact structural failure causing the shock state without removing the patient from the resuscitation area.
3
Evaluate the standard procedural interventions for the conflicting pathologies.
Standard tamponade treatment (pericardiocentesis) is absolutely contraindicated because relieving the external pericardial pressure will drastically increase stroke volume and aortic wall shear stress, causing the weakened aorta to completely rupture.
Understanding the physiologic interplay between the dissection and the effusion prevents a fatal iatrogenic error.
4
Determine the definitive procedural management.
The patient must be taken immediately to the operating room for a median sternotomy to simultaneously relieve the tamponade and repair the torn aorta.
Open surgery is the only intervention that definitively addresses both the structural tear and the obstructive shock without precipitating an immediate arrest.

Key Concept

In patients with a Stanford Type A aortic dissection complicated by cardiac tamponade, pericardiocentesis is absolutely contraindicated. The immediate next step is urgent open surgical repair.
Estimated Time:1m 30s
Question 752Question →

A 15-year-old girl is brought to the clinic by her mother due to the absence of menstrual periods. She has never experienced a menstrual bleed. The patient reports no cyclical pelvic pain, headaches, visual changes, or loss of smell. Her past medical history is unremarkable, and she takes no medications. She plays high school volleyball but does not engage in extreme physical training. She is at the 35th percentile for height and 45th percentile for weight. Vital signs are within normal limits. Physical examination reveals Tanner stage 1 breast development and Tanner stage 1 pubic hair. There is no clitoromegaly or severe acne. A transabdominal pelvic ultrasound is performed and demonstrates a normal-appearing prepubertal uterus, cervix, and bilateral ovaries. Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Serum follicle-stimulating hormone concentration

Answer

Serum follicle-stimulating hormone concentration
The correct answer is serum follicle-stimulating hormone (FSH) concentration. The evaluation of primary amenorrhea follows a strict diagnostic algorithm. The initial steps involve a physical examination to assess for secondary sexual characteristics (specifically breast development, which indicates estrogen exposure) and a pelvic ultrasound to determine the presence or absence of a uterus. In this patient, the ultrasound confirms that a uterus is present, but her physical examination shows absent breast development (Tanner stage 1). This combination indicates a lack of ovarian estrogen production. To determine whether the lack of estrogen is due to a primary ovarian defect (peripheral) or a lack of stimulation from the central nervous system (central), the hypothalamic-pituitary-ovarian axis must be evaluated. The most appropriate next step is to measure serum FSH. If the FSH is elevated (hypergonadotropic hypogonadism), it suggests primary ovarian insufficiency, and the next step would be a karyotype to evaluate for Turner syndrome (45,X). If the FSH is low or inappropriately normal (hypogonadotropic hypogonadism), it suggests a central cause (e.g., functional hypothalamic amenorrhea, Kallmann syndrome, or a pituitary lesion), and the next step would involve an MRI of the brain and further pituitary hormone testing.

Step-by-Step Solution

1
Identify the clinical presentation and age criteria for primary amenorrhea.
The patient is a 15-year-old female with no menarche and absent secondary sexual characteristics (Tanner stage 1 breasts), which meets the criteria for primary amenorrhea evaluation.
Evaluation is indicated at age 15 regardless of secondary sexual characteristics, or at age 13 if secondary sexual characteristics are absent.
2
Follow the primary amenorrhea diagnostic algorithm based on physical exam and initial imaging findings.
The first branch point is confirming pelvic anatomy via ultrasound. The stem states a normal uterus and ovaries are present.
The presence or absence of a uterus broadly divides the etiologies (e.g., Müllerian agenesis vs. functional hypothalamic amenorrhea).
3
Determine the next diagnostic test based on the presence of the uterus and the state of breast development.
Because the uterus is present but breast development is absent, the patient has an estrogen-deficient state.
Estrogen is required for breast development. The absence of breasts means the ovaries are not producing estrogen, either due to primary ovarian failure or lack of central stimulation.
4
Select the test that localizes the defect in the hypothalamic-pituitary-ovarian axis.
Measure the serum follicle-stimulating hormone (FSH) concentration.
An elevated FSH indicates hypergonadotropic hypogonadism (primary ovarian insufficiency, e.g., Turner syndrome), dictating a karyotype. A low or normal FSH indicates hypogonadotropic hypogonadism (central etiology), dictating an MRI of the brain and further endocrine workup.

Key Concept

In the diagnostic sequencing of primary amenorrhea, after confirming the presence of a uterus via ultrasound, the presence or absence of breast development dictates the next step. If breast development is absent, serum follicle-stimulating hormone (FSH) must be measured to distinguish between central and peripheral etiologies.
Estimated Time:1m 30s
Question 753Question →

An emergency response team is actively resuscitating a 34-year-old individual who was found unresponsive with continuous, generalized tonic-clonic movements. Paramedics report the seizure activity has persisted without interruption for at least 20 minutes prior to arrival. Two large-bore intravenous lines are rapidly secured. Vital signs show a blood pressure of 142/88142/88 mmHg, heart rate of 118118/min, and oxygen saturation of 96%96\% on high-flow oxygen. A point-of-care blood glucose reading is 112112 mg/dL. Arrange the following pharmacologic therapies in the correct sequential order of administration for the escalating algorithmic management of this condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with intravenous lorazepam, followed by a loading dose of fosphenytoin, then a continuous midazolam infusion, and finally a continuous pentobarbital infusion if the condition becomes super-refractory.
The established algorithmic approach to status epilepticus prioritizes the rapid cessation of seizure activity, followed by the prevention of recurrence, and progressively more suppressive therapies if seizures persist. Intravenous lorazepam provides the most rapid onset of action. Fosphenytoin is then loaded to establish durable seizure control. If seizures continue, continuous anesthetic infusions like midazolam are initiated. Pentobarbital is reserved for super-refractory cases due to its risk of profound hemodynamic collapse.

Step-by-Step Solution

1
Identify the clinical presentation as status epilepticus.
The patient has experienced greater than 5 minutes of continuous seizure activity.
Recognizing status epilepticus immediately triggers a strict, time-sensitive escalating pharmacologic protocol to prevent irreversible neurologic injury.
2
Select the first-line emergent medication.
Intravenous lorazepam.
Benzodiazepines have the fastest onset of action and are the most effective first-line agents for terminating active seizures.
3
Determine the subsequent urgent control therapy.
Intravenous fosphenytoin.
Because benzodiazepines have a short duration of action, a long-acting non-benzodiazepine antiseizure medication must be loaded to prevent seizure recurrence.
4
Determine the approach for refractory status epilepticus.
Continuous intravenous midazolam.
If seizures continue despite first- and second-line agents, continuous anesthetic infusions are required to achieve burst suppression on EEG.
5
Select the therapy for super-refractory cases.
Continuous intravenous pentobarbital.
When standard continuous anesthetics fail, highly suppressive barbiturate coma is initiated, though it is reserved for last due to severe side effects.

Key Concept

The algorithmic pharmacologic escalation for status epilepticus prioritizes rapid seizure cessation (benzodiazepines), followed by recurrence prevention (fosphenytoin/levetiracetam), and subsequently continuous deep sedation (midazolam/propofol) if seizures persist.
Estimated Time:1m 30s
Question 754Question →

A 71-year-old woman is evaluated in the emergency department for a 4-day history of progressively worsening productive cough, fever, and shortness of breath. Her past medical history is notable for type 2 diabetes mellitus, hypertension, and osteoarthritis. She lives independently at home. Her temperature is 38.8°C (101.8°F), blood pressure is 88/56 mmHg, pulse is 118/min, and respiratory rate is 32/min. Oxygen saturation is 89% on room air and improves to 94% on 4 L/min via nasal cannula. She is alert and oriented to person, place, and time.

Physical examination reveals coarse crackles and bronchial breath sounds over the right middle and left lower lung fields.

Laboratory results are as follows:
Leukocyte count: 16,500/mm³
Blood urea nitrogen: 34 mg/dL
Creatinine: 1.3 mg/dL
Platelet count: 180,000/mm³

A chest radiograph demonstrates dense alveolar infiltrates in the right middle and left lower lobes. Following the administration of 1.5 L of intravenous normal saline, her blood pressure improves to 106/64 mmHg. Empiric intravenous antibiotics are initiated.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Admission to the intensive care unit

Answer

Admission to the intensive care unit
The correct disposition is admission to the intensive care unit (ICU). This patient presents with community-acquired pneumonia (CAP) and demonstrates multiple high-risk features requiring intensive care. Disposition for CAP should be guided by objective risk stratification tools such as the CURB-65 score or the IDSA/ATS criteria for severe CAP. This patient's CURB-65 score is 4 (1 point each for Age >= 65, BUN > 19 mg/dL, Respiratory rate >= 30/min, and initial systolic blood pressure < 90 mmHg). A CURB-65 score of 3 or higher carries a high 30-day mortality risk and is a strong indication for ICU admission. Furthermore, she meets four IDSA/ATS minor criteria for severe CAP: respiratory rate >= 30/min, BUN >= 20 mg/dL, multilobar infiltrates, and hypotension requiring aggressive fluid resuscitation. The presence of three or more minor criteria firmly mandates ICU admission due to the high risk of impending respiratory failure or progressive shock.

Step-by-Step Solution

1
Calculate the patient's CURB-65 score based on the clinical presentation.
The score is 4 (1 point each for Age >= 65, BUN > 19 mg/dL, Respiratory rate >= 30/min, and initial blood pressure < 90/60 mmHg).
Objective severity scores are required to risk-stratify patients with community-acquired pneumonia to determine the appropriate care setting.
2
Evaluate the IDSA/ATS criteria for severe community-acquired pneumonia.
The patient meets four minor criteria (Respiratory rate >= 30/min, BUN >= 20 mg/dL, multilobar infiltrates, and hypotension requiring aggressive fluid resuscitation).
Meeting three or more minor IDSA/ATS criteria is an independent indication for ICU-level care.
3
Determine the appropriate disposition based on the objective risk stratification.
The patient requires admission to the intensive care unit.
Patients with a CURB-65 score of 3 or higher, or who meet criteria for severe pneumonia, have a high mortality risk and require intensive monitoring and care.

Key Concept

Risk stratification and appropriate care setting disposition for patients with community-acquired pneumonia using objective scoring systems (e.g., CURB-65, IDSA/ATS criteria).
Question 755Question →

A 23-year-old female college student presents to the university health clinic for a routine wellness examination. She reports feeling well and has no specific complaints. Her medical history is unremarkable, and she currently takes an oral contraceptive pill daily. She mentions that she recently became sexually active with a new male partner. Review of her immunization records confirms she completed the human papillomavirus (HPV) vaccine series at age 12. According to current United States Preventive Services Task Force (USPSTF) guidelines, which of the following screening interventions are indicated for this patient during today's visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Cervical cytology alone; Nucleic acid amplification testing for Chlamydia trachomatis and Neisseria gonorrhoeae

Answer

The indicated interventions are cervical cytology alone and nucleic acid amplification testing for Chlamydia trachomatis and Neisseria gonorrhoeae.
The patient is a sexually active 23-year-old female. According to USPSTF guidelines, sexually active women under the age of 25 should be screened annually for Chlamydia trachomatis and Neisseria gonorrhoeae (Grade B recommendation). Additionally, routine cervical cancer screening begins at age 21, and for women aged 21 to 29, the recommendation is screening every 3 years with cervical cytology alone (Grade A recommendation). Both of these interventions directly apply to this patient's presentation.

Step-by-Step Solution

1
Analyze the patient's demographic and social history.
The patient is a 23-year-old sexually active female with a new partner.
Age and sexual activity status dictate specific USPSTF preventive screening recommendations in young adult females.
2
Determine appropriate cervical cancer screening for her age group.
Cervical cytology alone is indicated.
For women aged 21 to 29, the USPSTF recommends screening every 3 years with cytology alone. Co-testing or primary HPV testing is reserved for women aged 30 and older.
3
Determine appropriate sexually transmitted infection (STI) screening.
Chlamydia and gonorrhea screening is indicated.
The USPSTF recommends screening for chlamydia and gonorrhea in all sexually active women 24 years or younger, as well as in older women who are at increased risk.

Key Concept

Preventive screening guidelines for sexually active young adult females
Question 756Question →

A 68-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) is being prepared for hospital discharge following an acute exacerbation. He initially presented with hypoxemic respiratory failure requiring noninvasive positive pressure ventilation. He has since improved and will be discharged on continuous home oxygen therapy, which is a new requirement for him. He also has a newly prescribed inhaler regimen. To ensure a safe transition of care and minimize readmission risk, arrange the following discharge planning steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first document clinical stability, then complete medication reconciliation, followed by verifying home equipment delivery, scheduling outpatient follow-up, and finally performing teach-back education.
The correct sequence follows the standardized principles of safe care transitions. Medical stability must be achieved first to prevent premature discharge. Once stable, medication reconciliation is performed to finalize the discharge orders. These orders then dictate the necessary home resources, so verifying equipment delivery comes next. With the plan and resources in place, a specific follow-up appointment is scheduled. Finally, just prior to physical discharge, the teach-back method is used to ensure the patient comprehensively understands the finalized plan, new medications, and equipment use.

Step-by-Step Solution

1
Assess medical readiness.
Clinical stability on the required oxygen flow rate is documented.
Prevents premature discharge and establishes the baseline for the discharge plan.
2
Finalize the medical plan.
Medication reconciliation is completed.
Ensures correct orders are generated for the discharge process and ongoing management.
3
Coordinate home resources.
Home oxygen delivery and setup are verified.
Ensures a safe physical environment is ready for the patient upon arrival at home.
4
Arrange continuity of care.
A specific follow-up appointment is scheduled.
Provides a safety net and ongoing medical surveillance after the transition.
5
Verify patient understanding.
Teach-back education is completed.
Confirms the patient understands the comprehensive, finalized plan right before leaving the hospital.

Key Concept

Safe transitions of care require a chronological approach: establishing medical stability, finalizing orders (medication reconciliation), securing resources (DME), ensuring continuity (follow-up), and confirming patient comprehension (teach-back).
Question 757Question →

A 42-year-old man presents to the emergency department with sudden-onset shortness of breath and right-sided pleuritic chest pain. He has a history of focal onset seizures, which have been well controlled on carbamazepine for the past five years. Vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 132/84 mm Hg132/84\text{ mm Hg}, heart rate 105/min105/\text{min}, respiratory rate 20/min20/\text{min}, and oxygen saturation 95%95\% on room air. Physical examination reveals clear lungs and a swollen, tender right calf. A computed tomography pulmonary angiogram reveals a segmental pulmonary embolism in the right lower lobe. Laboratory studies reveal a serum creatinine of 0.9 mg/dL0.9\text{ mg/dL} and normal hepatic function. Which of the following is the most appropriate pharmacologic intervention for this patient?

Show answer & explanation

Answer: Initiate low-molecular-weight heparin and transition to warfarin

Answer

Initiate low-molecular-weight heparin and transition to warfarin
The correct intervention is to initiate a low-molecular-weight heparin and transition to warfarin. This patient has a hemodynamically stable pulmonary embolism. While direct oral anticoagulants (DOACs) are typically first-line, this patient is taking carbamazepine, a strong inducer of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp). DOACs (e.g., apixaban, rivaroxaban) rely heavily on these pathways for metabolism and transport. Coadministration with strong inducers leads to significantly decreased DOAC plasma concentrations, increasing the risk of recurrent thromboembolism. Because warfarin dosing is individualized and titrated to an objective measure (the International Normalized Ratio, or INR), it can be safely used in patients on CYP inducers by adjusting the dose to maintain therapeutic efficacy.

Step-by-Step Solution

1
Diagnose the acute condition based on clinical and radiographic findings.
The patient has a deep vein thrombosis and a hemodynamically stable pulmonary embolism.
Tender/swollen calf indicates DVT, and the CT angiogram confirms a segmental PE with stable vital signs (normotension).
2
Determine the standard first-line therapy for the acute condition.
Direct oral anticoagulants (DOACs) such as apixaban or rivaroxaban are typically first-line for hemodynamically stable venous thromboembolism.
DOACs are preferred over warfarin in the general population due to ease of use and lower bleeding risk.
3
Review the patient's medication list for interactions that contraindicate standard therapy.
The patient is taking carbamazepine, a strong inducer of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp).
DOACs are heavily metabolized by CYP3A4 and are substrates of P-gp. Coadministration with strong inducers leads to significantly decreased DOAC plasma concentrations and therapeutic failure.
4
Select the safest alternative pharmacologic intervention.
Initiate a low-molecular-weight heparin (LMWH) bridge to a titratable vitamin K antagonist (warfarin).
Warfarin dosing is individualized and titrated to an objective measure (the International Normalized Ratio). The dose can be safely increased to maintain therapeutic efficacy despite the presence of CYP inducers.

Key Concept

Patients requiring anticoagulation who are taking strong CYP3A4 and P-glycoprotein inducers (e.g., carbamazepine, rifampin, phenytoin) should not receive direct oral anticoagulants (DOACs) due to the risk of subtherapeutic levels; they require a heparin bridge to a titratable vitamin K antagonist (warfarin).
Question 758Question →

Paramedics transport an 8282-year-old female to the acute care area following a syncopal episode at her residence. Her family reports she complained of severe dizziness and chest heaviness immediately before losing consciousness. Her medical history is significant for hypertension, hyperlipidemia, and a myocardial infarction three years ago. Upon arrival, the patient is lethargic and profoundly diaphoretic. Vital signs show a temperature of 36.4∘C36.4^\circ\text{C} (97.5∘F97.5^\circ\text{F}), blood pressure of 72/40 mmHg72/40\text{ mmHg}, pulse of 28/min28/\text{min}, and respiratory rate of 18/min18/\text{min}. Oxygen saturation is 94%94\% on room air. Physical examination reveals cool, clammy extremities with a capillary refill time of 4 seconds4\text{ seconds}. Jugular venous distention is absent, and lung fields are clear to auscultation bilaterally. A 1212-lead electrocardiogram displays regular P waves at a rate of 90/min90/\text{min} and regular, broad QRS complexes (0.16 sec0.16\text{ sec}) at a rate of 28/min28/\text{min} with complete dissociation between the atria and ventricles. Two large-bore intravenous lines are secured. Which of the following is the most appropriate next step in the stabilization of this patient?

Show answer & explanation

Answer: Immediate application of transcutaneous pacing pads

Answer

Immediate application of transcutaneous pacing pads
The patient is in cardiogenic shock secondary to a third-degree atrioventricular block with a wide QRS escape rhythm. According to Advanced Cardiovascular Life Support (ACLS) guidelines, unstable bradycardia requires immediate intervention to restore perfusion. While atropine is often the first-line pharmacologic agent for unstable bradycardia, it works by inhibiting vagal tone primarily at the AV node. In complete heart block with a wide QRS complex, the block is located below the AV node (in the His-Purkinje system). Atropine is generally ineffective for infranodal blocks and may even induce paradoxical slowing. Therefore, immediate electrical stabilization with transcutaneous pacing is the most appropriate and direct next step to re-establish cardiac output while preparing for transvenous pacemaker placement.

Step-by-Step Solution

1
Interpret the clinical presentation and vital signs.
The patient is in cardiogenic shock (hypotension, altered mental status, diaphoresis, delayed capillary refill) driven by profound bradycardia (pulse 28/min28/\text{min}).
Identifying the presence of shock and its primary driver is the first step in the ACLS bradycardia algorithm.
2
Analyze the electrocardiogram (ECG) findings.
The ECG shows AV dissociation with P waves faster than QRS complexes, confirming third-degree (complete) AV block. The broad QRS (0.16 sec0.16\text{ sec}) indicates an escape rhythm originating below the AV node (infranodal or His-Purkinje system).
The level of the block dictates the appropriate therapeutic intervention.
3
Determine the most appropriate immediate stabilization therapy.
Because the block is infranodal, atropine is unlikely to be effective and transcutaneous pacing must be initiated immediately to restore cardiac output.
ACLS guidelines state that atropine should not be relied upon for wide-complex complete heart blocks; electrical pacing or chronotropic infusions are the standard of care for these unstable patients.

Key Concept

In patients with hemodynamically unstable third-degree atrioventricular block featuring a wide QRS complex (infranodal block), immediate transcutaneous pacing is the preferred initial stabilization step because atropine is generally ineffective at the His-Purkinje level.
Question 759Question →

A 5454-year-old man with a history of stage 44 chronic kidney disease presents to the emergency department complaining of generalized muscle weakness and palpitations that started earlier today. His vital signs are stable, but his electrocardiogram reveals peaked T waves and widened QRS complexes. Laboratory results show a serum potassium level of 7.67.6 mEq/L. Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute stabilization and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing severe hyperkalemia with electrocardiographic changes is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and dextrose, 3) Oral sodium zirconium cyclosilicate.
The correct sequence for managing severe symptomatic hyperkalemia prioritizes immediate life threats before definitive treatment. The first and most critical step is stabilizing the cardiac myocyte membrane with intravenous calcium gluconate to prevent fatal arrhythmias. Once the myocardium is protected, the second step is rapidly shifting potassium from the extracellular space to the intracellular space using intravenous regular insulin paired with dextrose. The final step is definitively removing excess potassium from the body, which can be accomplished using gastrointestinal potassium binders such as oral sodium zirconium cyclosilicate.

Step-by-Step Solution

1
Identify the life-threatening condition and its immediate risk.
The patient has severe hyperkalemia with electrocardiogram changes (widened QRS complexes), indicating an imminent risk of ventricular arrhythmias.
Recognizing the severity dictates that immediate cardiac protection takes precedence over definitive potassium removal.
2
Select the initial cardioprotective agent.
Administer intravenous calcium gluconate.
Calcium antagonizes the membrane actions of hyperkalemia, stabilizing the cardiac conduction system without altering the serum potassium concentration.
3
Select the temporizing intracellular shifting agent.
Administer intravenous regular insulin and dextrose.
Insulin drives potassium into cells via the Na-K-ATPase pump, rapidly lowering serum potassium within minutes. Dextrose is given to prevent hypoglycemia.
4
Select the definitive elimination agent.
Administer a gastrointestinal potassium binder like oral sodium zirconium cyclosilicate.
This removes excess total body potassium over several hours to days, providing a permanent solution to the hyperkalemia.

Key Concept

Management sequence of severe symptomatic hyperkalemia
Question 760Question →

A 24-year-old woman is brought to the emergency department by paramedics after being found unresponsive in her apartment. Paramedics note an empty bottle of amitriptyline on the nightstand. On arrival, she is obtunded and only withdraws her extremities from painful stimuli. Her Glasgow Coma Scale score is 8. Vital signs are temperature 36.8∘C36.8^\circ\text{C} (98.2∘F98.2^\circ\text{F}), blood pressure 80/50 mmHg, pulse 135/min, and respiratory rate 10/min. A point-of-care electrocardiogram reveals sinus tachycardia with a QRS duration of 160 ms160\text{ ms} and a prominent terminal R wave in lead aVR.

Arrange the following management steps in the most appropriate chronological sequence for this patient's initial stabilization and subsequent care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of steps is: 1. Secure the airway via rapid sequence endotracheal intubation; 2. Administer a rapid intravenous bolus of sodium bicarbonate; 3. Administer activated charcoal via an orogastric tube; 4. Consult the psychiatry service for evaluation of intentional overdose.
The fundamental algorithm for initial stabilization dictates that Airway and Breathing must precede Circulation, Decontamination, and Disposition. For this patient, a Glasgow Coma Scale score of 8 necessitates immediate endotracheal intubation (Airway). Following airway protection, the profound TCA-induced cardiotoxicity (QRS 160 ms160\text{ ms}, hypotension) must be aggressively managed with an intravenous sodium bicarbonate bolus to prevent ventricular arrhythmias (Circulation). Once the patient is stabilized and the airway is protected from aspiration, gastrointestinal decontamination with activated charcoal can be safely performed via an orogastric tube. Finally, after the patient is fully resuscitated and medically cleared, a psychiatric consultation is required to address the intentional overdose.

Step-by-Step Solution

1
Assess the patient's respiratory status and level of consciousness.
The patient has a Glasgow Coma Scale score of 8 and a respiratory rate of 10/min, indicating an inability to protect the airway and impending respiratory failure.
Initial toxicological resuscitation must strictly adhere to the ABCs (Airway, Breathing, Circulation). Endotracheal intubation is the immediate first step.
2
Assess the patient's hemodynamic and electrocardiographic status.
The patient is hypotensive with a significantly widened QRS complex (160 ms160\text{ ms}), indicative of life-threatening sodium channel blockade from TCA toxicity.
Once the airway is secure, the most imminent threat to life is fatal ventricular arrhythmia. Intravenous sodium bicarbonate must be administered immediately as a targeted cardioprotective antidote.
3
Evaluate the indication and safety of gastrointestinal decontamination.
Activated charcoal is beneficial for absorbing unabsorbed TCA from the gut, but doing so in an obtunded patient without a protected airway is extremely dangerous.
Activated charcoal should only be administered via an orogastric tube AFTER the airway has been secured with an endotracheal tube to eliminate the risk of massive aspiration.
4
Determine the requirements for final disposition and specialty consultation.
The patient requires a formal psychiatric evaluation due to a high-lethality intentional overdose.
Psychiatric consultation is a crucial part of holistic management but must be deferred until the patient is completely physiologically stabilized, extubated, and capable of participating in an interview.

Key Concept

The initial stabilization of severe toxicological emergencies prioritizes airway protection (intubation for GCS ≤8\leq 8) before the administration of targeted antidotes (sodium bicarbonate for TCA-induced wide QRS), followed by gastrointestinal decontamination only when the airway is secure, and finally psychiatric disposition.
Estimated Time:1m 30s
PreviousPage 38 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 38 | Examkin